Senate Bill
S. 932
Give Kids a Chance Act of 2025
Primary Sponsor
Christopher Murphy
Senator
Cosponsors
2
Quick Stats
Policy Area
Summary
The Give Kids a Chance Act of 2025 aims to improve the development and testing of cancer drugs for children. It requires additional research on combining existing cancer drugs with new active ingredients to create more effective pediatric treatments. The bill also gives the FDA more authority to request relevant data from drug manufacturers to inform pediatric cancer studies.
Latest Action
Became Public Law No: 118-192.
See this page through your district lens
Enter ZIP to personalize representatives and vote context.
Stay on top of this issue
Subscribe for weekly bill and representative updates.
Vote Prediction
Give Kids a Chance Act of 2025
The Give Kids a Chance Act of 2025 aims to improve the development and testing of cancer drugs for children. It requires additional research on combining existing cancer drugs with new active ingredients to create more effective pediatric treatments. The bill
Community Breakdown
Pass
0%
Fail
0%
0 predictions
The Give Kids a Chance Act of 2025 aims to improve the development and testing of cancer drugs for children. It requires additional research on combining existing cancer drugs with new active ingredients to create more effective pediatric treatments. The bill also gives the FDA more authority to request relevant data from drug manufacturers to inform pediatric cancer studies.
- Bill Number
- 932
- Sponsor
- Christopher Murphy (D-CT)
- Introduced
- 11/6/2025
- Status
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Policy Area
- Congress
Data from Congress.gov
Fact Sheet
- Title
- Give Kids a Chance Act of 2025
- Bill Number
- 932
- Sponsor
- Christopher Murphy (D-CT)
- Status
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Introduced
- 11/6/2025
- Summary
- The Give Kids a Chance Act of 2025 aims to improve the development and testing of cancer drugs for children. It requires additional research on combining existing cancer drugs with new active ingredients to create more effective pediatric treatments. The bill also gives the FDA more authority to req
Data from Congress.gov
Public Opinions
Community submissions related to this bill.
No public opinions yet. Be the first to submit one for this bill.
Related Bills in Congress
Amending House Resolution 211 with respect to a national emergency declared by the President on February 1, 2025, and House Resolution 313 with respect to a national emergency declared by the President on April 2, 2025.
Referred to the House Committee on Rules.
Providing for consideration of the joint resolution (S.J. Res. 18) disapproving the rule submitted by the Bureau of Consumer Financial Protection relating to "Overdraft Lending: Very Large Financial Institutions"; providing for consideration of the joint resolution (S.J. Res. 28) disapproving the rule submitted by the Bureau of Consumer Financial Protection relating to "Defining Larger Participants of a Market for General-Use Digital Consumer Payment Applications"; providing for consideration of the bill (H.R. 1526) to amend title 28, United States Code, to limit the authority of district courts to provide injunctive relief, and for other purposes; providing for consideration of the bill (H.R. 22) to amend the National Voter Registration Act of 1993 to require proof of United States citizenship to register an individual to vote in elections for Federal office, and for other purposes; and for other purposes.
Motion to reconsider laid on the table Agreed to without objection.
A resolution recognizing the designation of the week of April 11 through April 17, 2023, as the sixth annual "Black Maternal Health Week" to bring national attention to the maternal health crisis in the United States and the importance of reducing maternal mortality and morbidity among Black women and birthing persons.
Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S1213-1214)
Electing a Member to a certain standing committee of the House of Representatives.
Motion to reconsider laid on the table Agreed to without objection.